Drug
Zw171
Zw171: highest development phase Phase 1, developed by Zymeworks. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zymeworks
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZW171 NCT06523803 | Phase 1 | Mesothelin-expressing Advanced Cancers |
Latest
No recent events.
Follow Zw171 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.